U
ACGN

UBS’s Aceragen Inc ACGN Stock Holding History

UBS’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$17K Sell
54
-63
-54% -$22.7K ﹤0.01% 8223
2014
Q2 		$46K Buy
117
+7
+6% +$2.89K ﹤0.01% 6990
2014
Q1 		$61K Buy
+110
New +$75.3K ﹤0.01% 6587

Other funds holding ACGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

UBS's ACGN Position: Q3 2014 in Review

UBS increased its Aceragen Inc (ACGN) stake by 238% in Q3 2014, buying an estimated $22.3K and bringing the position to 88 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #7571.

UBS first reported a position in ACGN in Q1 2014 and has held it in 3 quarters since. The position peaked at $713K in Q1 2014. 62 funds tracked by Wall St. Rank hold ACGN as of Q3 2014.

  • UBS held 88 shares of Aceragen Inc worth $28K as of Q3 2014.
  • UBS bought 62 Aceragen Inc shares in Q3 2014, an estimated $22.3K.
  • Aceragen Inc made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7571 holding.
  • UBS first reported a position in Aceragen Inc in Q1 2014 and has held it in 3 quarters since.
  • UBS's Aceragen Inc position peaked at $713K in Q1 2014.
  • 62 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.